Josh Riggs - Sep 28, 2025 Form 4 Insider Report for Insight Molecular Diagnostics Inc. (IMDX)

Role: CEO and President, Director
Signature: /s/ Josh Riggs
Stock symbol: IMDX
Transactions as of: Sep 28, 2025
Transactions value $: $0
Form type: 4
Date filed: 9/30/2025, 04:05 PM
Previous filing: Mar 28, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Riggs Josh	CEO and President, Director	C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE	/s/ Josh Riggs	2025-09-30	0001956391

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMDX	Option to Purchase Common Stock	Award	$0	+400K		$0.00	400K	Sep 28, 2025	Common Stock	400K	$3.33	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.